Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27322 | 18647236 | Liver Int | Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. | 2008 | Details |
| A27339 | 18617457 | Orv Hetil | [Non-alcoholic fatty liver disease and cardiovascular risk]. | 2008 | Details |
| A27342 | 18613418 | Hepatogastroenterology | Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. | 2008 | Details |
| A27343 | 18612181 | Endocr J | Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature. | 2008 | Details |
| A27358 | 18564173 | Diabetes Obes Metab | Current treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27362 | 18554746 | J Hepatol | Liver and heart: a new link? | 2008 | Details |
| A27369 | 18516264 | Ther Clin Risk Manag | Treatment of non-alcoholic fatty liver disease. | 2007 | Details |
| A27373 | 19669306 | Hepatol Int | Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report. | 2008 | Details |
| A27375 | 19669303 | Hepatol Int | Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors. | 2008 | Details |
| A27387 | 18492418 | Cir Cir | [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease]. | 2009 | Details |
| A27392 | 18486862 | J Adolesc Health | Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. | 2008 | Details |
| A27406 | 18461515 | Z Gastroenterol | Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients. | 2008 | Details |
| A27417 | 18422468 | Expert Opin Pharmacother | Pleiotropic effects of thiazolidinediones. | 2008 | Details |
| A27419 | 18420211 | Atherosclerosis | Do we need to consider inflammatory markers when we treat atherosclerotic disease? | 2008 | Details |
| A27420 | 18419637 | J Dig Dis | Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. | 2008 | Details |
| A27424 | 18410557 | Aliment Pharmacol Ther | Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2008 | Details |
| A27425 | 18405489 | Gastroenterol Hepatol | [Treatment of fatty liver disease]. | 2008 | Details |
| A27426 | 18403941 | Eur J Gastroenterol Hepatol | Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes. | 2008 | Details |
| A27436 | 18390575 | Gut | Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. | 2008 | Details |
| A27438 | 18386618 | Rom J Intern Med | Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease. | 2006 | Details |
| A27439 | 18384521 | Liver Int | Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. | 2008 | Details |
| A27452 | 18367860 | Korean J Hepatol | [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. | 2008 | Details |
| A27453 | 18367854 | Korean J Hepatol | [Nonalcoholic steatohepatitis: pathogenesis and treatment]. | 2008 | Details |
| A27457 | 18349115 | Am J Physiol Endocrinol Metab | A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. | 2008 | Details |
| A27462 | 18338077 | Rev Diabet Stud | First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease. | 2008 | Details |
| A27472 | 18324772 | J Agric Food Chem | Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. | 2008 | Details |
| A27487 | 18299664 | Minerva Gastroenterol Dietol | The clinical aspects of non-alcoholic fatty liver disease. | 2008 | Details |
| A27491 | 18289064 | Curr Pharm Des | Models for non-alcoholic fatty liver disease: a link with vascular risk. | 2008 | Details |
| A27524 | 18187226 | Diabetes Res Clin Pract | Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease? | 2008 | Details |
| A27528 | 18178378 | J Autoimmun | Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. | 2008 | Details |
| A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
| A27546 | 18088037 | Srp Arh Celok Lek | [Ultrasonography findings of liver in textile workers for diagnosing nonalcoholic fatty liver disease]. | 2008 | Details |
| A27554 | 18075282 | J Endocrinol Invest | Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. | 2007 | Details |
| A27561 | 18062158 | Praxis (Bern 1994) | [Non-alcoholic steatohepatitis--a new epidemic]. | 2007 | Details |
| A27563 | 18058083 | Diabetologia | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. | 2007 | Details |
| A27577 | 17935056 | Diab Vasc Dis Res | The role of fenofibrate in clinical practice. | 2007 | Details |
| A27606 | 17917083 | Med Oncol | A case-control study of non-alcoholic fatty liver disease in breast cancer. | 2007 | Details |
| A27612 | 17904683 | Diabetes Res Clin Pract | Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2007 | Details |
| A27619 | 17902213 | Int J Pediatr Obes | Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. | 2006 | Details |
| A27621 | 17900249 | Liver Int | Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. | 2007 | Details |
| A27629 | 17877759 | Clin Endocrinol (Oxf) | Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases. | 2007 | Details |
| A27631 | 17875176 | J Intern Med | Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. | 2007 | Details |
| A27632 | 17874726 | Vojnosanit Pregl | [Non-alcoholic fatty liver disease in obese persons with diabetes]. | 2007 | Details |
| A27638 | 17846888 | Dig Dis Sci | Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. | 2007 | Details |
| A27643 | 17786142 | Ann Hepatol | Prevalence of non-alcoholic fatty liver disease: population based study. | 2007 | Details |
| A27648 | 17764776 | Diabetes Res Clin Pract | Probable NAFLD, by ALT levels, and diabetes among Filipino-American women. | 2007 | Details |
| A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
| A27663 | 17567458 | J Gastroenterol Hepatol | Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? | 2007 | Details |
| A27667 | 17709876 | Cell Biochem Biophys | Childhood obesity and insulin resistance. | 2007 | Details |
| A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
| A27677 | 17690317 | Arterioscler Thromb Vasc Biol | Fatty liver: a novel component of the metabolic syndrome. | 2007 | Details |
| A27689 | 17659713 | World J Gastroenterol | Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. | 2007 | Details |
| A27691 | 17657385 | Singapore Med J | Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. | 2007 | Details |
| A27705 | 17608855 | J Gastroenterol Hepatol | Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. | 2007 | Details |
| A27708 | 17605315 | Nutr Rev | Obesity and nonalcoholic fatty liver disease. | 2007 | Details |
| A27710 | 17596883 | Hepatology | A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. | 2007 | Details |
| A27717 | 17565631 | J Gastroenterol Hepatol | How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | 2007 | Details |
| A27718 | 17565630 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. | 2007 | Details |
| A27723 | 17560678 | J Hepatol | Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A27729 | 17547835 | Curr Diab Rep | Nonalcoholic fatty liver disease and cardiovascular disease risk. | 2007 | Details |
| A27734 | 17544974 | Clin Liver Dis | Metabolic syndrome and NASH. | 2007 | Details |
| A27736 | 17544972 | Clin Liver Dis | Pathogenesis of NASH: animal models. | 2007 | Details |
| A27741 | 17542290 | Trop Gastroenterol | Nonalcoholic fatty liver disease in India--is it different? | 2007 | Details |
| A27745 | 17542277 | Rev Gastroenterol Mex | [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico]. | 2007 | Details |
| A27761 | 17498218 | J Gastroenterol Hepatol | What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | 2007 | Details |
| A27763 | 17496360 | Indian J Med Res | The metabolic syndrome in South Asians: continuing escalation & possible solutions. | 2007 | Details |
| A27772 | 17479322 | Surg Endosc | Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. | 2007 | Details |
| A27786 | 17452309 | Orv Hetil | [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. | 2007 | Details |
| A27790 | 17439070 | Recenti Prog Med | [Obesity in adolescents: physical correlated pathologies, and therapeutic state of art]. | 2007 | Details |
| A27792 | 17420951 | Dig Dis Sci | The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. | 2007 | Details |
| A27793 | 17419265 | Hepatogastroenterology | Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD. | 2007 | Details |
| A27802 | 17399848 | J Hepatol | Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. | 2007 | Details |
| A27829 | 17331160 | Alcohol Clin Exp Res | Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. | 2007 | Details |
| A27838 | 17297427 | Ann Hepatol | Fatty liver: experience from western India. | 2007 | Details |
| A27842 | 17294310 | Surg Endosc | Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients. | 2007 | Details |
| A27843 | 17287148 | Clin Gastroenterol Hepatol | Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2007 | Details |
| A27844 | 17277038 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
| A27855 | 17242448 | Nutr Clin Pract | Nonalcoholic Fatty liver disease and obesity. | 2007 | Details |
| A27863 | 17220609 | Intern Med | 1. Fatty liver and non-alcoholic steatohepatitis. | 2007 | Details |
| A27876 | 17167710 | Rev Med Chil | [Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease]. | 2006 | Details |
| A27878 | 17164082 | Nutr Metab Cardiovasc Dis | Diabetes and liver disease: an ominous association. | 2007 | Details |
| A27882 | 17143543 | Int J Mol Med | Pulmonary exposure to diesel exhaust particles enhances fatty change of the liver in obese diabetic mice. | 2007 | Details |
| A27897 | 17063117 | J Clin Gastroenterol | Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. | 2007 | Details |
| A27906 | 17049925 | Trends Mol Med | Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. | 2006 | Details |
| A27932 | 16959622 | J Formos Med Assoc | Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease. | 2006 | Details |
| A27934 | 16956020 | Praxis (Bern 1994) | [Non-alcoholic liver disease (NASH)]. | 2006 | Details |
| A27935 | 16953843 | Liver Int | Incretin mimetics as a novel therapeutic option for hepatic steatosis. | 2006 | Details |
| A27938 | 16942668 | Curr Treat Options Gastroenterol | Nonalcoholic Fatty Liver Disease (NAFLD): Approach in the Adolescent Patient. | 2006 | Details |
| A27940 | 16940890 | J Clin Gastroenterol | Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. | 2006 | Details |
| A27946 | 16931493 | Obesity (Silver Spring) | Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. | 2006 | Details |
| A27956 | 16904946 | Clin Gastroenterol Hepatol | Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A27957 | 16901766 | Clin Gastroenterol Hepatol | Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A27958 | 16899321 | J Hepatol | Hepatic histology in obese patients undergoing bariatric surgery. | 2006 | Details |
| A27959 | 16898568 | Curr Diab Rep | Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. | 2006 | Details |
| A27966 | 16856589 | J Indian Med Assoc | Hepatitis C and diabetes mellitus. | 2006 | Details |
| A27971 | 16832839 | Diabetes Metab Res Rev | Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. | 2006 | Details |
| A27977 | 16817817 | Clin Endocrinol (Oxf) | Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. | 2006 | Details |
| A27990 | 16778754 | Minerva Cardioangiol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2006 | Details |
| A28003 | 16768103 | Nihon Rinsho | [Current trends of NASH/NAFLD in Asia-Pacific region]. | 2006 | Details |
| A28006 | 16762007 | Liver Int | Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. | 2006 | Details |